FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094506525> ?p ?o ?g. }

• W2094506525 endingPage "20" @default.
• W2094506525 startingPage "7" @default.
• W2094506525 abstract "The purpose of this study was to compare the safety and efficacy of the short-acting β1-receptor blocker, landiolol hydrochloride (0.06 and 0.125-mg/kg), to placebo during coronary computed tomography angiography (CTA) in a phase 2 dose-finding study. A total of 183 patients suspected of having ischemic cardiac disease and scheduled to undergo an invasive coronary angiography were randomized to groups treated with landiolol hydrochloride (0.06 or 0.125-mg/kg) or placebo. The heart rate, safety, and the performance of coronary diagnosis using landiolol hydrochloride were evaluated in a multicenter, double-blind, randomized, parallel study. The patients’ heart rates during the coronary CTA were 67.6 ± 8.7 and 62.6 ± 7.8 beats/min in the 0.06 and 0.125-mg/kg landiolol hydrochloride groups, respectively, both of which were significantly lower than the heat rate of 73.7 ± 11.8 beats/min in the placebo group (P = 0.003 and P < 0.001, respectively). No adverse events or reactions occurred at an incidence of 5 % or greater, confirming the safety of landiolol hydrochloride. The proportion of correctly classified patients was significantly higher in the 0.125-mg/kg landiolol hydrochloride group than in the placebo group (73.6 vs. 50.0 %). Landiolol hydrochloride at doses of 0.06 and 0.125-mg/kg significantly decreased the heart rate compared with a placebo. The present findings suggest that landiolol hydrochloride is safe and useful at a dose of 0.125-mg/kg to improve coronary diagnostic performance during coronary CTA." @default.
• W2094506525 created "2016-06-24" @default.
• W2094506525 creator A5004909684 @default.
• W2094506525 creator A5012132556 @default.
• W2094506525 creator A5019791546 @default.
• W2094506525 creator A5026898221 @default.
• W2094506525 creator A5071383994 @default.
• W2094506525 creator A5071803207 @default.
• W2094506525 creator A5071947905 @default.
• W2094506525 creator A5078931094 @default.
• W2094506525 creator A5090876880 @default.
• W2094506525 date "2013-06-01" @default.
• W2094506525 modified "2023-09-27" @default.
• W2094506525 title "A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease" @default.
• W2094506525 cites W1260204519 @default.
• W2094506525 cites W1435982856 @default.
• W2094506525 cites W1979043393 @default.
• W2094506525 cites W1996618322 @default.
• W2094506525 cites W2003009267 @default.
• W2094506525 cites W2009555874 @default.
• W2094506525 cites W2034294110 @default.
• W2094506525 cites W2039013600 @default.
• W2094506525 cites W2040774967 @default.
• W2094506525 cites W2050508877 @default.
• W2094506525 cites W2052186469 @default.
• W2094506525 cites W2052977262 @default.
• W2094506525 cites W2056762281 @default.
• W2094506525 cites W2092457526 @default.
• W2094506525 cites W2105231355 @default.
• W2094506525 cites W2113235311 @default.
• W2094506525 cites W2132259559 @default.
• W2094506525 cites W2157498742 @default.
• W2094506525 cites W2164987356 @default.
• W2094506525 cites W2334854831 @default.
• W2094506525 doi "https://doi.org/10.1007/s10554-013-0253-3" @default.
• W2094506525 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3722440" @default.
• W2094506525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23784548" @default.
• W2094506525 hasPublicationYear "2013" @default.
• W2094506525 type Work @default.
• W2094506525 sameAs 2094506525 @default.
• W2094506525 citedByCount "12" @default.
• W2094506525 countsByYear W20945065252013 @default.
• W2094506525 countsByYear W20945065252014 @default.
• W2094506525 countsByYear W20945065252016 @default.
• W2094506525 countsByYear W20945065252017 @default.
• W2094506525 countsByYear W20945065252018 @default.
• W2094506525 countsByYear W20945065252020 @default.
• W2094506525 countsByYear W20945065252021 @default.
• W2094506525 crossrefType "journal-article" @default.
• W2094506525 hasAuthorship W2094506525A5004909684 @default.
• W2094506525 hasAuthorship W2094506525A5012132556 @default.
• W2094506525 hasAuthorship W2094506525A5019791546 @default.
• W2094506525 hasAuthorship W2094506525A5026898221 @default.
• W2094506525 hasAuthorship W2094506525A5071383994 @default.
• W2094506525 hasAuthorship W2094506525A5071803207 @default.
• W2094506525 hasAuthorship W2094506525A5071947905 @default.
• W2094506525 hasAuthorship W2094506525A5078931094 @default.
• W2094506525 hasAuthorship W2094506525A5090876880 @default.
• W2094506525 hasBestOaLocation W20945065251 @default.
• W2094506525 hasConcept C126322002 @default.
• W2094506525 hasConcept C142724271 @default.
• W2094506525 hasConcept C178790620 @default.
• W2094506525 hasConcept C185592680 @default.
• W2094506525 hasConcept C197934379 @default.
• W2094506525 hasConcept C204787440 @default.
• W2094506525 hasConcept C27081682 @default.
• W2094506525 hasConcept C2776460385 @default.
• W2094506525 hasConcept C2777953023 @default.
• W2094506525 hasConcept C42219234 @default.
• W2094506525 hasConcept C71924100 @default.
• W2094506525 hasConcept C84393581 @default.
• W2094506525 hasConceptScore W2094506525C126322002 @default.
• W2094506525 hasConceptScore W2094506525C142724271 @default.
• W2094506525 hasConceptScore W2094506525C178790620 @default.
• W2094506525 hasConceptScore W2094506525C185592680 @default.
• W2094506525 hasConceptScore W2094506525C197934379 @default.
• W2094506525 hasConceptScore W2094506525C204787440 @default.
• W2094506525 hasConceptScore W2094506525C27081682 @default.
• W2094506525 hasConceptScore W2094506525C2776460385 @default.
• W2094506525 hasConceptScore W2094506525C2777953023 @default.
• W2094506525 hasConceptScore W2094506525C42219234 @default.
• W2094506525 hasConceptScore W2094506525C71924100 @default.
• W2094506525 hasConceptScore W2094506525C84393581 @default.
• W2094506525 hasIssue "S1" @default.
• W2094506525 hasLocation W20945065251 @default.
• W2094506525 hasLocation W20945065252 @default.
• W2094506525 hasLocation W20945065253 @default.
• W2094506525 hasLocation W20945065254 @default.
• W2094506525 hasOpenAccess W2094506525 @default.
• W2094506525 hasPrimaryLocation W20945065251 @default.
• W2094506525 hasRelatedWork W1977915442 @default.
• W2094506525 hasRelatedWork W1984226278 @default.
• W2094506525 hasRelatedWork W2064879719 @default.
• W2094506525 hasRelatedWork W2085830368 @default.
• W2094506525 hasRelatedWork W2163740414 @default.
• W2094506525 hasRelatedWork W2170431845 @default.
• W2094506525 hasRelatedWork W2358466040 @default.
• W2094506525 hasRelatedWork W2409251209 @default.

• next